LEFLUNOMIDE (has an active metabolite) | LEFLUNOMIDE | ATC L04AA13
IMMUNOMODULATIONG AGENT PYRIMIDINE SYNTHESIS INHIBITOR TREATMENT OF PATIENTS WITH RELAPSING FORMS OF MULTIPLE SCLEROSIS ANTIINFLAMMATORY | ORAL | | DIHYDROOROTATE DEHYDROGENASE | DIHYDROOROTATE DEHYDROGENASE INHIBITOR CHEMBL1966 DIHYDROOROTATE DEHYDROGENASE Q02127 DIHYDROOROTATE DEHYDROGENASE (QUINONE), MITOCHONDRIAL HOMO SAPIENS ENZYME REDUCTASE | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |